Dillard James E III 4

4 · PERRIGO Co plc · Filed Mar 7, 2023

Form 4

Period: 2023-03-03

EVP, Chief Scientific Officer

Transactions

Award
Ordinary Shares
2023-03-03$38.75/sh+10,277$398,234→ 33,215 total
Tax Payment
Ordinary Shares
2023-03-03$38.75/sh−4,690$181,738→ 28,525 total
Exercise/Conversion
Ordinary Shares
2023-03-03$38.75/sh+1,995$77,306→ 30,520 total
Tax Payment
Ordinary Shares
2023-03-03$38.75/sh−900$34,875→ 29,620 total
Exercise/Conversion
Ordinary Shares
2023-03-03$38.75/sh+2,680$103,850→ 32,300 total
Tax Payment
Ordinary Shares
2023-03-03$38.75/sh−1,209$46,849→ 31,091 total
Exercise/Conversion
Restricted Stock Units
2023-03-03−1,995→ 0 total
→ Ordinary Shares (1,995 underlying)
Exercise/Conversion
Restricted Stock Units
2023-03-03−2,680→ 2,680 total
→ Ordinary Shares (2,680 underlying)

Footnotes (6)

[F1]Vesting of performance-based restricted stock units granted on March 5, 2020.
[F2]Vesting of service-based restricted stock units granted on March 5, 2020.
[F3]Vesting of service-based restricted stock units granted on March 5, 2021.
[F4]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
[F5]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2021.
[F6]Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.

Documents

2 files